Furosemide Basi

Medicinal product

(Invented) name

Furosemide Basi

Active substance (s)

Furozemidas

Strength

10 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03CA01, Furosemide

Marketing authorisation holder

Laboratórios Basi-Indústria Farmacêutica, S.A., Portugalija

Date of authorisation

2023-10-27

Date of renewal

Documents

5253_pakuotes lapeilis_2023-10-27.docx

5253_Furosemide Basi.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PT/H/2724/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Furozemidas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111873	97988	1097988	ampulė	2 ml N50		Receptinis	LT/1/23/5253/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-10-27	Registruotas